Louis-Jean et al., 2019 - Google Patents
Nutritionally attenuating the human gut microbiome to prevent and manage metabolic syndromeLouis-Jean et al., 2019
- Document ID
- 10481686032735350126
- Author
- Louis-Jean S
- Martirosyan D
- Publication year
- Publication venue
- Journal of agricultural and food chemistry
External Links
Snippet
Metabolic syndrome (MSyn) constitutes a litany of pathophysiological conditions, such as central adiposity, hypertension, dyslipidemia, and hyperglycemia. As a result of the epidemic levels of MSyn, several efforts have been made to identify the etiologies of the condition and …
- 208000001145 Metabolic Syndrome 0 title abstract description 186
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cronin et al. | Dietary fibre modulates the gut microbiota | |
De Filippis et al. | Dietary interventions to modulate the gut microbiome—how far away are we from precision medicine | |
Vacca et al. | The controversial role of human gut lachnospiraceae | |
Cui et al. | Roles of intestinal Parabacteroides in human health and diseases | |
Redondo-Useros et al. | Microbiota and lifestyle: a special focus on diet | |
Green et al. | Microbial medicine: prebiotic and probiotic functional foods to target obesity and metabolic syndrome | |
Hitch et al. | Microbiome-based interventions to modulate gut ecology and the immune system | |
Derrien et al. | The gut microbiota in the first decade of life | |
Battson et al. | The gut microbiota as a novel regulator of cardiovascular function and disease | |
Louis-Jean et al. | Nutritionally attenuating the human gut microbiome to prevent and manage metabolic syndrome | |
Pascale et al. | Microbiota and metabolic diseases | |
Cerdó et al. | The role of probiotics and prebiotics in the prevention and treatment of obesity | |
Pérez-Burillo et al. | Effect of food thermal processing on the composition of the gut microbiota | |
Li et al. | The gut microbiota: A treasure for human health | |
Harper et al. | The role of bacteria, probiotics and diet in irritable bowel syndrome | |
Binns | Probiotics, prebiotics and the gut microbiota. | |
Huang et al. | Interaction between gut immunity and polysaccharides | |
Salonen et al. | Impact of diet on human intestinal microbiota and health | |
Bonfrate et al. | Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options | |
Ferreira et al. | The central role of the gut microbiota in chronic inflammatory diseases | |
Buccigrossi et al. | Functions of intestinal microflora in children | |
Jones et al. | Emerging science of the human microbiome | |
Sánchez et al. | Adaptation of bifidobacteria to the gastrointestinal tract and functional consequences | |
Shabana et al. | The gut microbiota and its potential role in obesity | |
Huang et al. | Effect of probiotics therapy on nonalcoholic fatty liver disease |